REFERENCES
- Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global
cancer incidence and mortality in 2018: GLOBOCAN sources and methods.Int J Cancer . 2019;144(8):1941-1953.
- European association U [European Association of Urology
guidelines]. Edition. Vol. presented at the EAU Annual
Congress Amsterdam; 2020. Arnhem, The Netherlands: European
Association of Urology Guidelines Office:2020.
- Reisæter LA, Fütterer JJ, Halvorsen OJ, et al. 1.5-T multiparametric
MRI using PI-RADS: a region by region analysis to localize the
index-tumor of prostate cancer in patients undergoing prostatectomy.Acta radiol . 2015;56(4):500-511.
- Hoeks CM, Hambrock T, Yakar D, et al. Transition zone prostate cancer:
detection and localization with 3-T multiparametric MR imaging.Radiology . 2013;266(1):207-217.
- Eiber M, Weirich G, Holzapfel K, et al. Simultaneous 68Ga-PSMA HBED-CC
PET/MRI improves the localization of primary prostate cancer.Eur Urol . 2016;70(5):829-836.
- Hoffmann MA, Wieler HJ, Baues C, Kuntz NJ, Richardsen I,
Schreckenberger M. The impact of 68Ga-PSMA PET/CT and PET/MRI on the
management of prostate cancer. Urology . 2019;130:1-12.
- Weinreb JC, Barentsz JO, Choyke PL, et al. PI-RADS Prostate
Imaging–Reporting and Data System ; 2015, version 2. European
urology. 2016; vol 69(1):16-40.
- Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society
of Urological Pathology (ISUP) consensus conference on Gleason grading
of prostatic carcinoma: Definition of Grading Patterns and Proposal
for a New Grading System. Am J Surg Pathol . 2016;40(2):244-252.
- Perera M, Lawrentschuk N, Bolton D, Clouston D. Comparison of
contemporary methods for estimating prostate tumour volume in
pathological specimens. BJU Int . 2014;113(suppl 2):29-34.
- Arora R, Koch MO, Eble JN, et al. Heterogeneity of Gleason grade in
multifocal adenocarcinoma of the prostate. Cancer: interdisciplinary.Int J Am Cancer Society. 2004;100(11):2362-2366.
- de Rooij M, Hamoen EH, Witjes JA, Barentsz JO, Rovers MM. Accuracy of
magnetic resonance imaging for local staging of prostate cancer: a
diagnostic meta-analysis. Eur Urol . 2016;70(2):233-245.
- Drost FH, Osses DF, Nieboer D, et al. Prostate MRI, with or without
MRI‐targeted biopsy, and systematic biopsy for detecting prostate
cancer. Cochrane Database Syst Rev . 2019;4:CD012663.
- Le JD, Tan N, Shkolyar E, et al. Multifocality and prostate cancer
detection by multiparametric magnetic resonance imaging: correlation
with whole-mount histopathology. Eur Urol . 2015;67(3):569-576.
- Hartenbach M, Hartenbach S, Bechtloff W, et al. Combined PET/MRI
improves diagnostic accuracy in patients with prostate cancer: a
prospective diagnostic trial. Clin Cancer Res .
2014;20(12):3244-3253.
- Al-Bayati M, Grueneisen J, Lütje S, et al. Integrated 68gallium
labelled prostate-specific membrane antigen-11 positron emission
tomography/magnetic resonance imaging enhances discriminatory power of
multi-parametric prostate magnetic resonance imaging. Urol Int .
2018;100(2):164-171.
- de Perrot T, Rager O, Scheffler M, et al. Potential of hybrid 18
F-fluorocholine PET/MRI for prostate cancer imaging. Eur J Nucl
Med Mol Imaging . 2014;41(9):1744-1755.
- Lee MS, Cho JY, Kim SY, et al. Diagnostic value of integrated PET/MRI
for detection and localization of prostate cancer: comparative study
of multiparametric MRI and PET/CT. J Magn Reson Imaging .
2017;45(2):597-609.
- Hicks RM, Simko JP, Westphalen AC, et al. Diagnostic accuracy of
68Ga-PSMA-11 PET/MRI compared with multiparametric MRI in the
detection of prostate cancer. Radiology . 2018;289(3):730-737.
- Jambor I, Kuisma A, Kähkönen E, et al. Prospective evaluation of 18
F-FACBC PET/CT and PET/MRI versus multiparametric MRI in
intermediate-to high-risk prostate cancer patients (FLUCIPRO trial).Eur J Nucl Med Mol Imaging . 2018;45(3):355-364.
- Park SY, Zacharias C, Harrison C, et al. Gallium 68 PSMA-11 PET/MR
imaging in patients with intermediate- or high-risk prostate cancer.Radiology . 2018;288(2):495-505.
- Li M, Huang Z, Yu H, Wang Y, Zhang Y, Song B. Comparison of PET/MRI
with multiparametric MRI in diagnosis of primary prostate cancer: A
meta-analysis. Eur J Rad . 2019;113:225-231.